Literature DB >> 15760997

Preventing neural tube defects in Europe: population based study.

Araceli Busby1, Lenore Abramsky, Helen Dolk, Ben Armstrong.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15760997      PMCID： PMC554030          DOI： 10.1136/bmj.330.7491.574

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects.

Authors:  M A Honein; L J Paulozzi; T J Mathews; J D Erickson; L Y Wong
Journal:  JAMA       Date:  2001-06-20       Impact factor: 56.272

2.  Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group.

Authors: 
Journal:  Lancet       Date:  1991-07-20       Impact factor: 79.321

3.  Incidence of open neural tube defects in Nova Scotia after folic acid fortification.

Authors:  Vidia L Persad; Michiel C Van den Hof; Johanne M Dubé; Pamela Zimmer
Journal:  CMAJ       Date:  2002-08-06       Impact factor: 8.262
  3 in total
  26 in total

Review 1.  EUROCAT: 25 years of European surveillance of congenital anomalies.

Authors:  H Dolk
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-09       Impact factor: 5.747

Review 2.  The changing incidence of myelomeningocele and its impact on pediatric neurosurgery: a review from the Children's Memorial Hospital.

Authors:  Robin M Bowman; Vanda Boshnjaku; David G McLone
Journal:  Childs Nerv Syst       Date:  2009-03-27       Impact factor: 1.475

3.  Levels of folate receptor autoantibodies in maternal and cord blood and risk of neural tube defects in a Chinese population.

Authors:  Na Yang; Linlin Wang; Richard H Finnell; Zhiwen Li; Lei Jin; Le Zhang; Robert M Cabrera; Rongwei Ye; Aiguo Ren
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2016-05-11

4.  Knowledge among young people about folic acid and its importance during pregnancy: a survey in the Federal State of Saxony-Anhalt (Germany).

Authors:  Simone Pötzsch; Jana Hoyer-Schuschke; Manuela Seelig; Volker Steinbicker
Journal:  J Appl Genet       Date:  2006       Impact factor: 3.240

Review 5.  Prevention of myelomeningocele: African perspectives.

Authors:  Taopheeq Bamidele Rabiu; Amos Olufemi Adeleye
Journal:  Childs Nerv Syst       Date:  2013-09-07       Impact factor: 1.475

6.  Association between health beliefs and health behavior in early pregnancy.

Authors:  Tamás Bödecs; Boldizsár Horváth; Eniko Szilágyi; Marietta Diffellné Németh; János Sándor
Journal:  Matern Child Health J       Date:  2011-11

7.  Congenital myelomeningocele - do we have to change our management?

Authors:  Steffi Mayer; Margit Weisser; Holger Till; Gerd Gräfe; Christian Geyer
Journal:  Cerebrospinal Fluid Res       Date:  2010-10-14

8.  Construction of a high resolution linkage disequilibrium map to evaluate common genetic variation in TP53 and neural tube defect risk in an Irish population.

Authors:  Faith Pangilinan; Kerry Geiler; Jessica Dolle; James Troendle; Deborah A Swanson; Anne M Molloy; Marie Sutton; Mary Conley; Peadar N Kirke; John M Scott; James L Mills; Lawrence C Brody
Journal:  Am J Med Genet A       Date:  2008-10-15       Impact factor: 2.802

9.  Analysis of the MTHFD1 promoter and risk of neural tube defects.

Authors:  Nicola Carroll; Faith Pangilinan; Anne M Molloy; James Troendle; James L Mills; Peadar N Kirke; Lawrence C Brody; John M Scott; Anne Parle-McDermott
Journal:  Hum Genet       Date:  2009-01-08       Impact factor: 4.132

10.  Orthopedic management of spina bifida. Part I: hip, knee, and rotational deformities.

Authors:  Vineeta T Swaroop; Luciano Dias
Journal:  J Child Orthop       Date:  2009-10-25       Impact factor: 1.548
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.